2011 Scrip Asia 100 - TeloVac tailwind helps KAEL-GemVax chart a course to market

 
• By Ian Haydock
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category